{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:38:06Z","timestamp":1790818686057,"version":"4.1.0"},"reference-count":76,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.beem.2019.04.007","type":"journal-article","created":{"date-parts":[[2019,4,13]],"date-time":"2019-04-13T10:40:59Z","timestamp":1555152059000},"page":"101273","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Peripheral precocious puberty including congenital adrenal hyperplasia: causes, consequences, management and outcomes"],"prefix":"10.1016","volume":"33","author":[{"given":"Nadine G.","family":"Haddad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica A.","family":"Eugster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.beem.2019.04.007_bib1","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1542\/pir.21.5.159","article-title":"Congenital adrenal hyperplasia","volume":"21","author":"Levine","year":"2000","journal-title":"Pediatr Rev"},{"issue":"11","key":"10.1016\/j.beem.2019.04.007_bib2","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1210\/jc.2018-01865","article-title":"Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an endocrine society clinical practice guideline","volume":"103","author":"Speiser","year":"2018","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"9477","key":"10.1016\/j.beem.2019.04.007_bib3","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/S0140-6736(05)66736-0","article-title":"Congenital adrenal hyperplasia","volume":"365","author":"Merke","year":"2005","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.beem.2019.04.007_bib4","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1073\/pnas.82.4.1089","article-title":"Two genes encoding steroid 21-hydroxylase are located near the genes encoding the fourth component of complement in man","volume":"82","author":"White","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"14","key":"10.1016\/j.beem.2019.04.007_bib5","doi-asserted-by":"crossref","first-page":"5111","DOI":"10.1073\/pnas.83.14.5111","article-title":"Structure of human steroid 21-hydroxylase genes","volume":"83","author":"White","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.beem.2019.04.007_bib6","first-page":"245","article-title":"Congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"21","author":"White","year":"2000","journal-title":"Endocr Rev"},{"issue":"1","key":"10.1016\/j.beem.2019.04.007_bib7","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1067\/mpd.2001.110527","article-title":"Height outcome in congenital adrenal hyperplasia caused by 21-hydroxylase deficiency: a meta-analysis","volume":"138","author":"Eugster","year":"2001","journal-title":"J\u00a0Pediatr"},{"issue":"5","key":"10.1016\/j.beem.2019.04.007_bib8","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1210\/jcem-58-5-857","article-title":"True precocious puberty complicating congenital adrenal hyperplasia: treatment with a luteinizing hormone-releasing hormone analog","volume":"58","author":"Pescovitz","year":"1984","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.beem.2019.04.007_bib9","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.beem.2019.04.007_bib10","doi-asserted-by":"crossref","first-page":"143","DOI":"10.7326\/0003-4819-96-2-143","article-title":"Late-onset 21-hydroxylase deficiency mimicking idiopathic hirsutism or polycystic ovarian disease","volume":"96","author":"Chrousos","year":"1982","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.beem.2019.04.007_bib11","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.ecl.2015.07.009","article-title":"Infertility and reproductive function in patients with congenital adrenal hyperplasia: pathophysiology, advances in management, and recent outcomes","volume":"44","author":"Lekarev","year":"2015","journal-title":"Endocrinol Metab Clin N Am"},{"issue":"3","key":"10.1016\/j.beem.2019.04.007_bib12","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1530\/EJE-11-0828","article-title":"Fertility, sexuality and testicular adrenal rest tumors in adult males with congenital adrenal hyperplasia","volume":"166","author":"Falhammar","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.beem.2019.04.007_bib13","doi-asserted-by":"crossref","first-page":"155 e1","DOI":"10.1016\/j.jpurol.2017.11.011","article-title":"Testicular adrenal rest tumor screening and fertility counseling among males with congenital adrenal hyperplasia","volume":"14","author":"Chaudhari","year":"2018","journal-title":"J\u00a0Pediatr Urol"},{"issue":"3","key":"10.1016\/j.beem.2019.04.007_bib14","doi-asserted-by":"crossref","first-page":"E524","DOI":"10.1210\/jc.2014-2036","article-title":"Molecular characterization of testicular adrenal rest tumors in congenital adrenal hyperplasia: lesions with both adrenocortical and Leydig cell features","volume":"100","author":"Smeets","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2019.04.007_bib15","series-title":"Congenital adrenal hyperplasia","author":"Levine LS","year":"2007"},{"key":"10.1016\/j.beem.2019.04.007_bib16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13633-016-0035-5","article-title":"Differential effects of hydrocortisone, prednisone, and dexamethasone on hormonal and pharmacokinetic profiles: a pilot study in children with congenital adrenal hyperplasia","volume":"2016","author":"Nebesio","year":"2016","journal-title":"Int J Pediatr Endocrinol"},{"issue":"1","key":"10.1016\/j.beem.2019.04.007_bib17","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4103\/0970-1591.45532","article-title":"Feminizing genital reconstruction in congenital adrenal hyperplasia","volume":"25","author":"Leslie","year":"2009","journal-title":"Indian J Urol: IJU: journal of the Urological Society of India"},{"issue":"5 Suppl","key":"10.1016\/j.beem.2019.04.007_bib18","first-page":"1796","article-title":"Congenital adrenal hyperplasia: current surgical management at academic medical centers in the United States","volume":"193","author":"Sturm","year":"2015","journal-title":"J\u00a0Urol"},{"issue":"3","key":"10.1016\/j.beem.2019.04.007_bib19","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1210\/jc.2002-020782","article-title":"Effects on gender identity of prenatal androgens and genital appearance: evidence from girls with congenital adrenal hyperplasia","volume":"88","author":"Berenbaum","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2019.04.007_bib20","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1749-6632.1993.tb43873.x","article-title":"Congenital adrenal hyperplasia complicated by central precocious puberty: treatment with LHRH-agonist analogue","volume":"687","author":"Dacou-Voutetakis","year":"1993","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"10.1016\/j.beem.2019.04.007_bib21","doi-asserted-by":"crossref","first-page":"265","DOI":"10.14310\/horm.2002.1555","article-title":"Gonadotropin releasing hormone analog treatment in children with congenital adrenal hyperplasia complicated by central precocious puberty","volume":"14","author":"Guven","year":"2015","journal-title":"Hormones (Basel)"},{"issue":"6","key":"10.1016\/j.beem.2019.04.007_bib22","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1210\/jc.2004-2128","article-title":"Treatment with growth hormone and luteinizing hormone releasing hormone analog improves final adult height in children with congenital adrenal hyperplasia","volume":"90","author":"Lin-Su","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.beem.2019.04.007_bib23","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1210\/jc.2010-2699","article-title":"Final adult height in children with congenital adrenal hyperplasia treated with growth hormone","volume":"96","author":"Lin-Su","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"24","key":"10.1016\/j.beem.2019.04.007_bib24","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1056\/NEJM199112123252403","article-title":"Activating mutations of the stimulatory G protein in the McCune-Albright syndrome","volume":"325","author":"Weinstein","year":"1991","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.beem.2019.04.007_bib25","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0022-3476(05)80943-6","article-title":"Severe endocrine and nonendocrine manifestations of the McCune-Albright syndrome associated with activating mutations of stimulatory G protein GS","volume":"123","author":"Shenker","year":"1993","journal-title":"J\u00a0Pediatr"},{"issue":"6","key":"10.1016\/j.beem.2019.04.007_bib26","first-page":"653","article-title":"An update on the treatment of precocious puberty in McCune-Albright syndrome and testotoxicosis","volume":"20","author":"Haddad","year":"2007","journal-title":"J\u00a0Pediatr Endocrinol Metab JPEM J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.beem.2019.04.007_bib27","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1016\/j.jpag.2015.02.007","article-title":"Implications for the future of pediatric and adolescent girls with McCune-Albright syndrome: long term obstetrical and gynecologic Outcomes","volume":"28","author":"Casey","year":"2015","journal-title":"Oral Abstracts J Pediatr Adolesc Gynecol"},{"issue":"9","key":"10.1016\/j.beem.2019.04.007_bib28","doi-asserted-by":"crossref","first-page":"E1782","DOI":"10.1210\/jc.2012-1791","article-title":"Characterization and management of testicular pathology in McCune-Albright syndrome","volume":"97","author":"Boyce","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.beem.2019.04.007_bib29","first-page":"1778","article-title":"Macroorchidism due to autonomous hyperfunction of Sertoli cells and G(s)alpha gene mutation: an unusual expression of McCune-Albright syndrome in a prepubertal boy","volume":"86","author":"Coutant","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.beem.2019.04.007_bib30","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jpeds.2004.06.083","article-title":"Testicular microlithiasis: an unreported feature of McCune-Albright syndrome in males","volume":"145","author":"Wasniewska","year":"2004","journal-title":"J\u00a0Pediatr"},{"issue":"9","key":"10.1016\/j.beem.2019.04.007_bib31","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.jpedsurg.2007.04.021","article-title":"Oophorectomy in McCune-Albright syndrome: a case of mistaken identity","volume":"42","author":"Nabhan","year":"2007","journal-title":"J\u00a0Pediatr Surg"},{"issue":"1","key":"10.1016\/j.beem.2019.04.007_bib32","first-page":"81","article-title":"Ketoconazole treatment of gonadotropin independent precocious puberty in girls with McCune-Albright syndrome: a preliminary report","volume":"12","author":"Syed","year":"1999","journal-title":"J\u00a0Pediatr Endocrinol Metab JPEM (J Pediatr Endocrinol Metab)"},{"issue":"3","key":"10.1016\/j.beem.2019.04.007_bib33","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1124\/dmd.115.067744","article-title":"Evaluation of ketoconazole and its alternative clinical CYP3a4\/5 inhibitors as inhibitors of drug transporters: the in\u00a0vitro effects of ketoconazole, ritonavir, clarithromycin, and itraconazole on 13 clinically-relevant drug transporters","volume":"44","author":"Vermeer","year":"2016","journal-title":"Drug Metab Dispos Biological Fate Chem"},{"issue":"12","key":"10.1016\/j.beem.2019.04.007_bib34","doi-asserted-by":"crossref","first-page":"5730","DOI":"10.1210\/jc.2003-030864","article-title":"Lack of efficacy of fadrozole in treating precocious puberty in girls with the McCune-Albright syndrome","volume":"88","author":"Nunez","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.beem.2019.04.007_bib35","first-page":"647","article-title":"Long-term testolactone therapy for precocious puberty in girls with the McCune-Albright syndrome","volume":"77","author":"Feuillan","year":"1993","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.beem.2019.04.007_bib36","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1210\/jc.2007-2090","article-title":"The aromatase inhibitor anastrozole is ineffective in the treatment of precocious puberty in girls with McCune-Albright syndrome","volume":"93","author":"Mieszczak","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.beem.2019.04.007_bib37","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1530\/EJE-16-0526","article-title":"Long-term outcomes of letrozole treatment for precocious puberty in girls with McCune-Albright syndrome","volume":"175","author":"Estrada","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.beem.2019.04.007_bib38","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1210\/jc.2006-2350","article-title":"Letrozole treatment of precocious puberty in girls with the McCune-Albright syndrome: a pilot study","volume":"92","author":"Feuillan","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.beem.2019.04.007_bib39","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0022-3476(03)00128-8","article-title":"Tamoxifen treatment for precocious puberty in McCune-Albright syndrome: a multicenter trial","volume":"143","author":"Eugster","year":"2003","journal-title":"J\u00a0Pediatr"},{"issue":"3","key":"10.1016\/j.beem.2019.04.007_bib40","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000435881","article-title":"Tamoxifen improves final height prediction in girls with McCune-Albright syndrome: a long follow-up","volume":"84","author":"de GBPC","year":"2015","journal-title":"Hormone Res Paediatrics"},{"issue":"1","key":"10.1016\/j.beem.2019.04.007_bib41","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1687-9856-2012-26","article-title":"Fulvestrant treatment of precocious puberty in girls with McCune-Albright syndrome","volume":"2012","author":"Sims","year":"2012","journal-title":"Int J Pediatr Endocrinol"},{"issue":"2","key":"10.1016\/j.beem.2019.04.007_bib42","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1507\/endocrj.EJ11-0214","article-title":"Combined treatment with bicalutamide and anastrozole in a young boy with peripheral precocious puberty due to McCune-Albright Syndrome","volume":"59","author":"Tessaris","year":"2012","journal-title":"Endocr J"},{"issue":"1\u20132","key":"10.1016\/j.beem.2019.04.007_bib43","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000132962","article-title":"Localization of the human luteinizing hormone\/choriogonadotropin receptor gene (LHCGR) to chromosome 2p21","volume":"54","author":"Rousseau-Merck","year":"1990","journal-title":"Cytogenet Cell Genet"},{"issue":"6447","key":"10.1016\/j.beem.2019.04.007_bib44","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/365652a0","article-title":"A\u00a0constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty","volume":"365","author":"Shenker","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.beem.2019.04.007_bib45","series-title":"Testotoxicosis with an episodic course: an unusual case within a series","author":"Nabhan","year":"2018"},{"issue":"2","key":"10.1016\/j.beem.2019.04.007_bib46","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1210\/jcem-64-2-328","article-title":"Gonadotropin-independent precocious puberty (\"testotoxicosis\"): influence of maturational status on response to ketoconazole","volume":"64","author":"Holland","year":"1987","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.beem.2019.04.007_bib47","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1056\/NEJM198408233110807","article-title":"Male-limited familial precocious puberty in three generations. Apparent Leydig-cell autonomy and elevated glycoprotein hormone alpha subunit","volume":"311","author":"Reiter","year":"1984","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.beem.2019.04.007_bib48","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1159\/000185521","article-title":"Long-term outcome of male-limited gonadotropin-independent precocious puberty","volume":"48","author":"Bertelloni","year":"1997","journal-title":"Horm Res"},{"issue":"1","key":"10.1016\/j.beem.2019.04.007_bib49","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0022-3476(85)80460-1","article-title":"Pituitary gonadotropin-independent male-limited autosomal dominant sexual precocity in nine generations: familial testotoxicosis","volume":"106","author":"Egli","year":"1985","journal-title":"J\u00a0Pediatr"},{"issue":"1","key":"10.1016\/j.beem.2019.04.007_bib50","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1530\/eje.0.1390101","article-title":"Testicular seminoma in a patient with a constitutively activating mutation of the luteinizing hormone\/chorionic gonadotropin receptor","volume":"139","author":"Martin","year":"1998","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.beem.2019.04.007_bib51","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1067\/mpd.2001.114477","article-title":"Nodular Leydig cell hyperplasia in a boy with familial male-limited precocious puberty","volume":"138","author":"Leschek","year":"2001","journal-title":"J\u00a0Pediatr"},{"issue":"1","key":"10.1016\/j.beem.2019.04.007_bib52","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1365-2265.2007.03160.x","article-title":"Long-term treatment of familial male-limited precocious puberty (testotoxicosis) with cyproterone acetate or ketoconazole","volume":"69","author":"Almeida","year":"2008","journal-title":"Clin Endocrinol"},{"issue":"9","key":"10.1016\/j.beem.2019.04.007_bib53","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1111\/j.1651-2227.1994.tb13192.x","article-title":"Hazards of ketoconazole therapy in testotoxicosis","volume":"83","author":"Babovic-Vuksanovic","year":"1994","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.beem.2019.04.007_bib54","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jpeds.2017.07.047","article-title":"Effect of antiandrogen, aromatase inhibitor, and gonadotropin-releasing hormone analog on adult height in familial male precocious puberty","volume":"190","author":"Leschek","year":"2017","journal-title":"J\u00a0Pediatr"},{"issue":"3","key":"10.1016\/j.beem.2019.04.007_bib55","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jpeds.2006.04.027","article-title":"Treatment of familial male-limited precocious puberty with bicalutamide and anastrozole","volume":"149","author":"Kreher","year":"2006","journal-title":"J\u00a0Pediatr"},{"issue":"10","key":"10.1016\/j.beem.2019.04.007_bib56","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1515\/jpem.2010.161","article-title":"Bicalutamide plus anastrozole for the treatment of gonadotropin-independent precocious puberty in boys with testotoxicosis: a phase II, open-label pilot study (BATT)","volume":"23","author":"Reiter","year":"2010","journal-title":"J\u00a0Pediatr Endocrinol Metab : JPEM (J Pediatr Endocrinol Metab)"},{"issue":"3","key":"10.1016\/j.beem.2019.04.007_bib57","doi-asserted-by":"crossref","first-page":"e728","DOI":"10.1542\/peds.2010-0596","article-title":"Bicalutamide and third-generation aromatase inhibitors in testotoxicosis","volume":"126","author":"Lenz","year":"2010","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.beem.2019.04.007_bib58","first-page":"439","article-title":"Ovarian sex cord-stromal tumors in children and adolescents","volume":"50","author":"Schneider","year":"2005","journal-title":"J\u00a0Reprod Med"},{"issue":"3","key":"10.1016\/j.beem.2019.04.007_bib59","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/00003081-197709000-00010","article-title":"Ovarian tumors in children and adolescents","volume":"20","author":"Breen","year":"1977","journal-title":"Clinical Obstetrics Gynecol"},{"issue":"6","key":"10.1016\/j.beem.2019.04.007_bib60","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.jpeds.2012.05.039","article-title":"Leydig cell tumors in children: contrasting clinical, hormonal, anatomical, and molecular characteristics in boys and girls","volume":"161","author":"Olivier","year":"2012","journal-title":"J\u00a0Pediatr"},{"issue":"2","key":"10.1016\/j.beem.2019.04.007_bib61","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1464-410X.1967.tb09800.x","article-title":"Prepubertal gynaecomastia in association with an interstitial-cell tumour of the testis","volume":"39","author":"Johnstone","year":"1967","journal-title":"Br J Urol"},{"issue":"11","key":"10.1016\/j.beem.2019.04.007_bib62","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1097\/00000478-199811000-00006","article-title":"Leydig cell tumor of the testis: a clinicopathologic, DNA content, and MIB-1 comparison of nonmetastasizing and metastasizing tumors","volume":"22","author":"Cheville","year":"1998","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.beem.2019.04.007_bib63","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/00000478-199501000-00007","article-title":"Feminizing Sertoli cell tumors in boys with Peutz-Jeghers syndrome","volume":"19","author":"Young","year":"1995","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.beem.2019.04.007_bib64","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s000180050329","article-title":"The molecular basis and clinical aspects of Peutz-Jeghers syndrome","volume":"55","author":"Hemminki","year":"1999","journal-title":"Cell Mol Life Sci CMLS"},{"issue":"4","key":"10.1016\/j.beem.2019.04.007_bib65","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.humpath.2006.01.029","article-title":"Extragonadal germ cell tumors are often associated with Klinefelter syndrome","volume":"37","author":"Aguirre","year":"2006","journal-title":"Hum Pathol"},{"issue":"4985","key":"10.1016\/j.beem.2019.04.007_bib66","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1126\/science.1978757","article-title":"Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms","volume":"250","author":"Malkin","year":"1990","journal-title":"Science"},{"issue":"16","key":"10.1016\/j.beem.2019.04.007_bib67","doi-asserted-by":"crossref","first-page":"9330","DOI":"10.1073\/pnas.161479898","article-title":"An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma","volume":"98","author":"Ribeiro","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.beem.2019.04.007_bib68","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/ajcp\/97.1.73","article-title":"New developments in the pathologic diagnosis of adrenal cortical neoplasms. A review","volume":"97","author":"Medeiros","year":"1992","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"10.1016\/j.beem.2019.04.007_bib69","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1200\/JCO.2004.08.085","article-title":"Clinical and outcome characteristics of children with adrenocortical tumors: a report from the International Pediatric Adrenocortical Tumor Registry","volume":"22","author":"Michalkiewicz","year":"2004","journal-title":"J\u00a0Clin Oncol Official J Am Soc Clinical Oncol"},{"issue":"6","key":"10.1016\/j.beem.2019.04.007_bib70","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0022-3468(97)90649-7","article-title":"Childhood adrenocortical tumors: case series and reevaluation of prognosis--a 24-year experience","volume":"32","author":"Mayer","year":"1997","journal-title":"J\u00a0Pediatr Surg"},{"issue":"6","key":"10.1016\/j.beem.2019.04.007_bib71","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/BF03349073","article-title":"Effects of cyproterone acetate, LHRH agonist and ovarian surgery in McCune-Albright syndrome with precocious puberty and galactorrhea","volume":"11","author":"Carani","year":"1988","journal-title":"J\u00a0Endocrinol Investig"},{"issue":"1","key":"10.1016\/j.beem.2019.04.007_bib72","first-page":"44","article-title":"The effects of cyproterone acetate on statural growth in children with precocious puberty","volume":"115","author":"Sorgo","year":"1987","journal-title":"Acta Endocrinol"},{"issue":"1","key":"10.1016\/j.beem.2019.04.007_bib73","first-page":"29","article-title":"McCune Albright Syndrome (MCAS): a case series","volume":"40","author":"Rao","year":"2003","journal-title":"Indian Pediatr"},{"issue":"3","key":"10.1016\/j.beem.2019.04.007_bib74","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1210\/jcem-57-3-571","article-title":"Gonadotropin-independent familial sexual precocity with premature Leydig and germinal cell maturation (familial testotoxicosis): effects of a potent luteinizing hormone-releasing factor agonist and medroxyprogesterone acetate therapy in four cases","volume":"57","author":"Rosenthal","year":"1983","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.beem.2019.04.007_bib75","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1210\/jc.2004-1438","article-title":"Adult height after ketoconazole treatment in patients with familial male-limited precocious puberty","volume":"90","author":"Soriano-Guillen","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.beem.2019.04.007_bib76","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1210\/jcem.84.1.5413","article-title":"Six-year results of spironolactone and testolactone treatment of familial male-limited precocious puberty with addition of deslorelin after central puberty onset","volume":"84","author":"Leschek","year":"1999","journal-title":"J\u00a0Clin Endocrinol Metab"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X19300168?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X19300168?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:56:06Z","timestamp":1761497766000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X19300168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":76,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S1521690X19300168"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2019.04.007","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peripheral precocious puberty including congenital adrenal hyperplasia: causes, consequences, management and outcomes","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2019.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101273"}}